Targeted Interventions for Successful Transition and Transfer of Adolescents With Inborn Errors of Metabolism to Adult Services
Launched by UNIVERSITY CHILDREN'S HOSPITAL, ZURICH · Jun 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping teenagers with inborn errors of metabolism transition smoothly from pediatric to adult healthcare services. The researchers aim to understand how well these young patients are prepared for this change by assessing their knowledge about adult care, practical skills like making appointments, and their overall health and confidence. They will also provide structured support and resources to help improve these areas.
To participate in this trial, individuals should be at least 14 years old and currently receiving care for a metabolic condition in a specialized clinic. They need to have a clear disease marker that doctors can measure. Participants will be involved in evaluations to see how the support affects their readiness for adult care both shortly after the intervention and again six to twelve months later. Importantly, the study is actively recruiting and welcomes patients of all genders, offering an opportunity for them to gain valuable skills for their health journey.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:Patients
- • with an inborn error of metabolism in the care of a specialized metabolic care unit
- • requiring specialized adult metabolic care
- • at least 14 years old
- • with a disease for which at least one biochemical and / or physical parameter disease marker is well established .
- Exclusion Criteria:
- • Patients -
- • with insufficient knowledge of the German
- • with cognitive impairment to a degree that consent, and participation would be impossible
- • in an end-of-life situation
- • with a disease for which no biochemical and / or physical parameter disease marker is well established
About University Children's Hospital, Zurich
The University Children's Hospital Zurich is a leading academic medical institution dedicated to advancing pediatric healthcare through innovative research and clinical excellence. Affiliated with the University of Zurich, the hospital specializes in a wide range of pediatric disciplines, offering comprehensive care to children and adolescents. As a prominent sponsor of clinical trials, the institution is committed to exploring new therapies and improving treatment protocols, ensuring that young patients benefit from the latest advancements in medicine. With a focus on collaboration, the hospital engages in partnerships with researchers, healthcare professionals, and pharmaceutical companies to drive impactful studies that enhance the health and well-being of children globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Zürich, , Switzerland
Basel, , Switzerland
Zürich, , Switzerland
Vienna, , Austria
Vienna, , Austria
Bern, , Switzerland
Bern, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials